Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Global Psychiatrists Market Report 2022: Rising Government Support for Mental Health Reforms is Expected to Propel Growth
Company Logo
Company Logo

Global Psychiatrists Market

Global Psychiatrists Market
Global Psychiatrists Market

Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "Psychiatrists Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the global Psychiatrists market.

The global psychiatrists market is expected to grow from $234.03 billion in 2021 to $255.09 billion in 2022 at a compound annual growth rate (CAGR) of 9.0%. The psychiatrists market is expected to grow to $320.39 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.

  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.

  • Create regional and country strategies on the basis of local data and analysis.

  • Identify growth segments for investment.

  • Outperform competitors using forecast data and the drivers and trends shaping the market.

  • Understand customers based on the latest market research findings.

  • Benchmark performance against key competitors.

  • Utilize the relationships between key data sets for superior strategizing.

  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

The major players covered in the psychiatrists market are UK NHS, Universal Health Services, Massachusetts General Hospital, New York-Presbyterian University Hospital, Mayo Clinic, Johns Hopkins Hospital, McLean Hospital, Mental Health and Neurosciences, Vidyasagar Institute of Mental Health and Neurosciences, Central Institute of Psychiatry, Institute of Behaviour and Allied Sciences

The psychiatrist market consists of sales of psychiatrists' services and related goods by entities (organizations, sole traders, and partnerships) that provide the diagnosis, treatment, and prevention of mental, emotional, and behavioral disorders. The psychiatrist industry includes establishments of licensed practitioners having the degree of M.D. (Doctor of Medicine) or D.O. (Doctor of Osteopathic Medicine) that provide palliative care, treat psychosomatic disorders, mental disorders, and others. Psychiatrists operate private or group practices in their own offices (e.g., centers, clinics) or in the facilities of others, such as hospitals or health maintenance organization (HMO) medical centers.

The main mental disorder types of psychiatrists are alcohol abuse mental and behavioral disorders, psychoactive substance uses mental and behavioral disorders, schizophrenia, schizotypal and delusional disorders, mood (anxiety and depression) disorders, and other mental and behavioral disorders. The patient types are inpatient and outpatient. The psychology types are social, abnormal, biological, and others.

The regions covered in psychiatrists market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The rising government support for mental health reforms is expected to propel the growth of the psychiatrist market going forward. Support for mental health resources led to a demand for mental care and drove the psychiatrist market.